poisar

Stocks · News reference

BNP Paribas Maintains Neutral on Clorox, Lowers Price Target to $95

Jul 20, 2026, 5:17 PMBenzinga Newsdesk

BNP Paribas analyst Kevin Grundy maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $97 to $95.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CLX
Source
benzinga
Observed
Jul 20, 2026, 5:17 PM
Checked
Jul 20, 2026, 5:17 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Aug 5, 2026, 7:05 PMDaniel Foelber

    Meet the 5.1%-Yielding Stock That Just Increased Its Dividend for the 49th Consecutive Year. Here's Why It's a Buy in August.

    Clorox has increased its dividend for the 49th consecutive year and is positioned as an attractive value stock for income investors. The company's acquisition of Purell, completion of its ERP system overhaul, and strong projected free cash flow generation support its dividend sustainability. Despite challenging consumer spending conditions, Clorox trades at a valuation of 16.8x fiscal 2027 earnings guidance and is on track to become a Dividend King in 2027.

    Read original at the-motley-fool
    CLX